TheEdgeResearch
Home / Stocks / PXMBF

Paxman AB (publ) (PXMBF)

OTC Healthcare Medical - Devices
$3.50 ▲ +0.00%
Market Cap
$81.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.46
52-Wk Range
3.5-3.5
CEO
Richard Paxman
Country
SE
Currency
USD

Paxman AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Karlshamn, BL, SE. The stock last traded at $3.50, up 0.00% on the session, giving a market capitalisation of $81.5M. On trailing twelve-month figures it carries a trailing P/E of 993.81, a net margin of 0.4%. Its beta of 0.46 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
993.81
Price / Sales
3.91
Price / Book
3.46
EV / EBITDA
29.21
Gross margin
17.9%
Operating margin
2.3%
Net margin
0.4%
Return on equity
—
Debt / equity
0.03
Current ratio
4.18
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
144
IPO date
2019-04-23
Headquarters
Karlshamn, BL, SE
About Paxman AB (publ)

Paxman AB (publ), along with its subsidiaries, specializes in the creation and worldwide sale of the Paxman scalp cooling system, an innovative solution designed to minimize hair loss in patients undergoing chemotherapy. This system is distributed across Europe, the United States, Mexico, Japan, Oceania, various Asian regions, and both South and Central America, primarily serving cancer centers and hospitals. The company is also engaged in a research collaboration agreement with the National University Hospital in Singapore, working towards the development of a portable cooling and compression device. Established in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.

Comparable companies

Paxman AB (publ) is most often compared with the following Healthcare names:

BCCOYCLLKFHOFBFIMPZYLDXHFORXOYRCELSNZZFVMTHFVTIAF
More research on PXMBF
PXMBF technical analysis PXMBF TheEdge Score Compare against peers
Open full interactive analysis & DCF →